Literature DB >> 18376832

Shape-specific, monodisperse nano-molding of protein particles.

Jennifer Y Kelly1, Joseph M DeSimone.   

Abstract

Herein we report nano-molding proteins for the fabrication of protein PRINT particles of monodisperse size and shape. Lyophilized protein particles are generally highly dispersed in particle size, aggregated, and often made through costly and complicated processes. Attempts to engineer monodisperse, discrete protein particles using wet-milling, spray-freeze-drying, microemulsion, or super critical fluid methods have realized little success. The PRINT technology enables a gentle, facile route to monodisperse particles of 100% protein as small as 200 nm cylinders. Protein PRINT particles of any shape and size are effortlessly achievable. Our research efforts include making PRINT particles composed of albumin and albumin 0.5 wt % siRNA, and Abraxane, the gold standard therapeutic used in metastatic breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376832     DOI: 10.1021/ja8014428

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  36 in total

1.  Hydrogel microparticles from lithographic processes: novel materials for fundamental and applied colloid science.

Authors:  Matthew E Helgeson; Stephen C Chapin; Patrick S Doyle
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-04-01       Impact factor: 6.448

Review 2.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

4.  Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.

Authors:  Anton Beletskii; Ashley Galloway; Shyam Rele; Michele Stone; Frank Malinoski
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Engineering nanomedicines using stimuli-responsive biomaterials.

Authors:  Yapei Wang; James D Byrne; Mary E Napier; Joseph M DeSimone
Journal:  Adv Drug Deliv Rev       Date:  2012-01-14       Impact factor: 15.470

6.  Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles.

Authors:  Timothy J Merkel; Kevin P Herlihy; Janine Nunes; Ryan M Orgel; Jason P Rolland; Joseph M DeSimone
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

7.  Patterned Surface Energy in Elastomeric Molds as a Generalized Approach to Polymer Particle Fabrication.

Authors:  Samuel D Oberdick; Gary Zabow
Journal:  ACS Appl Polym Mater       Date:  2020

Review 8.  Self-assembled lipid nanomedicines for siRNA tumor targeting.

Authors:  Yu-Cheng Tseng; Leaf Huang
Journal:  J Biomed Nanotechnol       Date:  2009-08       Impact factor: 4.099

9.  Size-uniform 200 nm particles: fabrication and application to magnetofection.

Authors:  Lamar Mair; Kris Ford; M d Rowshon Alam; Ryszard Kole; Michael Fisher; Richard Superfine
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

Review 10.  Polymeric carriers: role of geometry in drug delivery.

Authors:  Eric A Simone; Thomas D Dziubla; Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.